Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

89.76% of the stock is owned by institutional investors and hedge funds. Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

The company was incorporated in 2000 and is headquartered in Mason, Ohio. Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom ...

Spinal Implants companies are Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical, etc ALBANY ...

PORTLAND, IL, UNITED STATES, January 30, 2025 /EINPresswire / -- Increase in the number of spinal & joint <a target=_blank href= ...

Atalanta Therapeutics is pioneering RNA interference (RNAi) for the treatment of neurological diseases, having developed a proprietary platform that, for the first time enables RNAi to be deployed as ...